Four legislators on Thursday introduced legislation that would restore over-the-counter medicines as qualified reimbursements under health spending accounts and flexible spending accounts without a prescription.
Amid debt ceiling talks, the National Association of Chain Drug Stores has sent a letter to President Barack Obama and to the U.S. House of Representatives and Senate leadership outlining key areas to help ensure continued patient access to pharmacy services through such federally funded programs as Medicare, Medicaid and TRICARE, the association announced on Wednesday.
One week after the Senate failed to pass an amendment that would have delayed swipe-fee reform for an additional 12 months, the Department of Justice Antitrust Division reportedly is addressing anticompetitive practices related to credit cards.
The Council for Responsible Nutrition on Wednesday announced the association has reached “a milestone of meetings,” having met with all 112 freshmen offices in the House and Senate within the first 60 legislative days of the 112th Congress.
The Louisiana State Senate has given the green light to legislation that would expand pharmacy's ability to administer immunizations, and now the House of Representatives is slated to vote on the legislation in the coming days. The passage of SB 60 is important because expanding the pharmacist's ability to administer vaccinations is a relatively low-cost way to expand access and ultimately improve outcomes.
The generic drug industry’s main lobby in Washington is hoping to head off cuts to the Food and Drug Administration’s Office of Generic Drugs, which it said could have a “devastating impact” on those who rely on generics.
The National Community Pharmacists Association has expressed support of legislation that seeks to overturn two provisions in the Obama healthcare law that limit a patient’s choice in how to use consumer-directed health savings plans.
Sen. Kay Hagan, D-N.C., argued before the Senate Thursday around the value that increased access to medication therapy management can deliver to overall health care — that includes cutting into the $290 billion in annual costs associated with medication nonadherence and preventing as many as 89,000 premature deaths.
The battle for the prescription status of methamphetamine precursor/popular cough-cold ingredient pseudoephedrine now is heating up in Kentucky, just a few days following a Nevada news report that suggested the state will be considering PSE prescription-only requirements just as soon as a bill is introduced by Nevada Sen. Sheila Leslie, D-Reno.